Safety and Efficacy of SP-103 in Subjects With Moderate to Severe Acute Lower Back Pain
Palo Alto (17 mi)Age: 18+
Sex: Any
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: Phase 2
Waitlist Available
Sponsor: Scilex Pharmaceuticals, Inc.
Prior Safety Data
Trial Summary
What is the purpose of this trial?This trial is testing SP-103, a skin-applied treatment, to see if it can help people with severe lower back pain. Participants will use the treatment regularly and note their pain levels. The goal is to find out if SP-103 can effectively reduce their pain.
Eligibility Criteria
Treatment Details
2Treatment groups
Experimental Treatment
Placebo Group
Group I: SP-103Experimental Treatment1 Intervention
One SP-103 transdermal system is worn 12 hours per day for 28 days on the lower back.
Group II: PlaceboPlacebo Group1 Intervention
One placebo transdermal system is worn for 12 hours per day for 28 days on the lower back
Find a clinic near you
Research locations nearbySelect from list below to view details:
Costal Clinical Research SpecialistsFernandina Beach, FL
Arizona Research CenterPhoenix, AZ
Scilex Research Site 01Boise, ID
Scilex Research Site 03Jacksonville, FL
More Trial Locations
Loading ...
Who is running the clinical trial?
Scilex Pharmaceuticals, Inc.Lead Sponsor
Worldwide Clinical TrialsCollaborator